Fraxiparin for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Amann
F W
FW
Department of Internal Medicine, University Hospital, Zurich, Switzerland.
Neuenschwander
C
C
Meyer
B J
BJ
D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000517:prevention & control*; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010865:Pilot Projects; D012008:Recurrence
D006495:Heparin, Low-Molecular-Weight